Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.19.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Restricted Stock Unit Activity
A summary of the Company’s restricted stock unit activity under the 2018 Plan is set forth below:
 
Shares
 
Weighted Average Grant Date Fair Value
Outstanding as of December 31, 2018

 
$

Granted
665,363

 
7.34

Released

 

Forfeited

 

Outstanding as of June 30, 2019
665,363

 
$
7.34

Stock-Based Compensation
A summary of the Company’s stock option activity under the Plan and related information is as follows:
 
Number of Shares
 
Weighted Average
Exercise Price
 
Weighted Average
Remaining
Contractual Term
(years)
 
Aggregate Intrinsic
Value
Outstanding as of December 31, 2018
2,364,823

 
$
0.90

 
8.12
 
$
71,332

Granted

 

 
 
 
 
Released
(106,397
)
 
0.68

 
 
 
 
Forfeited
(329,350
)
 
1.69

 
 
 
 
Outstanding as of June 30, 2019
1,929,076

 
$
0.78

 
7.07
 
$
4,492

Exercisable as of June 30, 2019
1,258,784

 
$
0.67

 
6.31
 
$
3,067

Schedule of Stock Options Granted
The fair value of stock options granted is estimated on the date of grant using the Black-Scholes option-pricing model. The following table sets forth information relating to stock options granted:
 
Three Months Ended June 30, 2018
 
Six Months Ended June 30, 2018
Weighted average risk-free rate
2.75%
 
2.51%
Expected dividend yield
 
Weighted average expected life (years)
6.08
 
6.08
Weighted average volatility
56.87%
 
56.87%
Condensed Income Statement
Compensation costs that have been included on the Company’s consolidated statements of operations and comprehensive income (loss) for all stock-based compensation arrangements are detailed as follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
Stock-based compensation
2019
 
2018
 
2019
 
2018
Cost of revenues
$
24

 
$
14

 
$
38

 
$
18

Sales and marketing
9

 
13

 
(16
)
 
15

General and administrative
349

 
27

 
372

 
151

Research and development
34

 
8

 
33

 
27

Total stock-based compensation
$
416

 
$
62

 
$
427

 
$
211